Clinical trials
Completed Phase 2 Leukemia, Erythroblastic, Acute trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 6 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 6 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 4 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 14 |
| Case Comprehensive Cancer Center | 6 |
| Fred Hutchinson Cancer Center | 4 |
| SWOG Cancer Research Network | 4 |
| Northwestern University | 3 |
| Alliance for Clinical Trials in Oncology | 2 |
| City of Hope Medical Center | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Asan Medical Center | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Erythroblastic, Acute | 51 |
| Leukemia, Myeloid, Acute | 49 |
| Leukemia, Megakaryoblastic, Acute | 47 |
| Leukemia, Monocytic, Acute | 45 |
| Leukemia, Myelomonocytic, Acute | 44 |
| Congenital Abnormalities | 34 |
| Leukemia | 26 |
| Leukemia, Basophilic, Acute | 12 |
| Leukemia, Eosinophilic, Acute | 12 |
| Leukemia, Promyelocytic, Acute | 9 |
Trials
Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.